10-KThe Record
Damora Therapeutics, Inc. files 10-K
Filed Mar 19, 2026 · 3mo ago · Accession 0001193125-26-115922
Plain English
Annual report — full-year financials, business overview, and risk factors.
Read the source below for the full document.
Filing details
- Company
- Damora Therapeutics, Inc.
- Ticker
- DMRA
- CIK
- 1800315
- Form type
- 10-K
- Filing date
- Mar 19, 2026
- Report date
- Dec 31, 2025
- Document
- dmra-20251231.htm
- Size
- 15.2 MB